
Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays
Author(s) -
Jonathan A. Lee,
Paul Shinn,
Susan Jaken,
Sarah E. Oliver,
Francis S. Willard,
Steven A. Heidler,
Robert B. Peery,
Jennifer Oler,
Shaoyou Chu,
Noel Southall,
Thomas S. Dexheimer,
Jeffrey K. Smallwood,
Ruili Huang,
Rajarshi Guha,
Ajit Jadhav,
Karen L. Cox,
Christopher P. Austin,
Anton Simeonov,
G. Sitta Sittampalam,
Saba Husain,
Natalie Franklin,
David Wild,
Jeremy J. Yang,
Jeffrey J. Sutherland,
Craig J. Thomas
Publication year - 2015
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0130796
Subject(s) - pubchem , phenotypic screening , drug discovery , pomalidomide , medicine , pazopanib , computational biology , pharmacology , druggability , bioinformatics , phenotype , biology , oncology , sunitinib , thalidomide , genetics , renal cell carcinoma , multiple myeloma , gene